Status:
COMPLETED
Early Ambulation to Reduce Hospital Length of Stay
Lead Sponsor:
University of Florida
Conditions:
Ambulation
Wearable Devices
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Early ambulation of inpatients has been shown to be a key driver of decreased LOS and also reduced adverse events such as venous thromboembolism (VTE). We will test if a patient wearable device (pedom...
Eligibility Criteria
Inclusion
- Patients ages \> or equal to 18 years
- Patient has capacity to undergo informed consent
- Admitted to UF Health Jacksonville 8N progressive inpatient unit
- Inpatient physician orders for patient ambulation and/or activity as tolerated upon hospital admission
- Patient with a Fall Predictive Analytics score category of "low risk"
- Patient with a Morse Fall Scale (MFS) of \< or equal to 50
- No contraindications to wearing a wrist pedometer (no skin breakdown, overlying skin infections, contact dermatitis, or indwelling catheters/need for venipuncture at wrist site)
Exclusion
- Patient \< 18 years of age
- Patient without capacity to undergo informed consent
- Patient with a 'do not ambulate' order or has order for bed rest or other contraindication to ambulation (i.e., fall risk) or dependent on more than minimal assistance to ambulate
- Patient with a Fall Predictive Analytics score category of "high risk"
- Patient with MFS \> 50 or labelled by clinical team as fall risk
- Non-English speaking
- In law enforcement custody or ward of the state
- Pregnancy
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04444453
Start Date
October 21 2020
End Date
September 1 2022
Last Update
January 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Jacksonville, Florida, United States, 32209